Randomised controlled trials may underestimate drug effects: balanced placebo trial design.
<h4>Background</h4>It is an inherent assumption in randomised controlled trials that the drug effect can be estimated by subtracting the response during placebo from the response during active drug treatment.<h4>Objective</h4>To test the assumption of additivity. The primary...
Guardado en:
Autores principales: | Karen Lund, Lene Vase, Gitte L Petersen, Troels S Jensen, Nanna B Finnerup |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3fe231dc7d28486780cd6b4e6322fc7f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Clinical use of pregabalin in the management of central neuropathic pain
por: Nanna B Finnerup, et al.
Publicado: (2007) -
Polymorphism in serotonin receptor 3B is associated with pain catastrophizing.
por: Emilia Horjales-Araujo, et al.
Publicado: (2013) -
A randomised, blinded, placebo-controlled trial in dementia patients continuing or stopping neuroleptics (the DART-AD trial).
por: Clive Ballard, et al.
Publicado: (2008) -
Efficacy of memantine for agitation in Alzheimer's dementia: a randomised double-blind placebo controlled trial.
por: Chris Fox, et al.
Publicado: (2012) -
A meta-analysis of randomised placebo-controlled treatment trials for depression and anxiety in Parkinson's disease.
por: Lakkhina Troeung, et al.
Publicado: (2013)